Third Rock Ventures Iii, L.P. Nurix Therapeutics, Inc. (NRIX) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of Nurix Therapeutics, Inc.. Currently has a direct ownership of 3.42 Million shares of NRIX, which is worth approximately $83.7 Million. The most recent transaction as insider was on May 06, 2021, when has been sold 1,085,784 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.42M

0% 3M change

0% 12M change

Total Value Held $83.7 Million

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 06 2021	SELL Other acquisition or disposition	-	1,085,784 Reduced 24.08%	3,422,549 Common Stock
Feb 04 2021	SELL Other acquisition or disposition	-	914,216 Reduced 16.86%	4,508,333 Common Stock
Jul 28 2020	BUY Conversion of derivative security	-	5,422,549 Added 50.0%	5,422,549 Common Stock

Also insider at

MYOK

MyoKardia Inc

> 10% Shareholder

VYGR

Voyager Therapeutics, Inc. Healthcare

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

> 10% Shareholder

RLAY

Relay Therapeutics, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

TRV